Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sanofi India Ltd Call Transcript 2026

Feb 19, 2026

59270_rns_2026-02-19_464e8724-eee9-42b1-ac33-0a8fcc16f876.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [111 x 29] intentionally omitted <==

19[th] February 2026

To The Secretary BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 Scrip Code: 500674

The Secretary The National Stock Exchange of India Limited Exchange Plaza, C-1, Block G, Bandra-Kurla Complex, Bandra (E), Mumbai 400 051 Symbol: SANOFI

Sub: Intimation of Investor / Analysts Call

Dear Sir / Madam,

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Company will hold an investor / analysts call for update on Audited Financial Results and Statements for the quarter and year ended 31[st] December 2025, the details of which are as follows:

Date: Thursday, 26thFebruary 2026
Time: 4:00 p.m. to 5:00 p.m. IST
Dial-in
details:
Diamond Pass Link Click Here
Universal Dial-in +91 22 6280 1191
+91 22 7115 8075
International Toll Free Argentina
0080014243444
Australia
0080014243444
Belgium
0080014243444
Canada
01180014243444
China
4008428405
France
0800914745
Germany
0080014243444
Hong Kong
800964448
Italy
0080014243444
Japan
00531161110
Netherlands
08000229808
Poland
008001124248
Singapore
8001012045
South Korea
00180014243444
Sweden
0080014243444
Thailand
00180014243444
UK
08081011573
USA
18667462133

Sanofi India Limited, Sanofi House, CTS No. 117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400 072 - India - Tel.: +91(22) 2803 2000 - Fax: +91(22) 2803 2939 Corporate Identity Number: L24239MH1956PLC009794 Website: www.sanofiindialtd.com | www.sanofi.in Email: [email protected]

==> picture [111 x 29] intentionally omitted <==

One way audio webcast of the Conference Call will be hosted on the Click Here following link Pre-registration is required. Registration will remain open till 12 p.m. IST on 26[th] February 2026. Investors will get an opportunity to view the presentation and ask questions to the Company Management in the sequence of their registration.

Kindly take the above information on record.

Yours faithfully

For Sanofi India Limited Haresh Digitally signed by Haresh Bachubhai Bachubhai Vala Date: 2026.02.19 Vala 15:31:38 +05'30' ___

Haresh Vala Company Secretary & Compliance Officer Membership No: A18246

Sanofi India Limited, Sanofi House, CTS No. 117-B, L&T Business Park, Saki Vihar Road, Powai, Mumbai 400 072 - India - Tel.: +91(22) 2803 2000 - Fax: +91(22) 2803 2939 Corporate Identity Number: L24239MH1956PLC009794 Website: www.sanofiindialtd.com | www.sanofi.in Email: [email protected]